Price for prescription drugs subject to the Medicare Drug Price Negotiation Program established.
Introduction and first reading, referred to; Authors added
Summary
The bill creates a "maximum fair price" for prescription drugs that the federal Medicare negotiation program determines, and it forbids manufacturers from charging more than that amount. Health plans and pharmacy benefit managers must reimburse pharmacies at least that price (or the NADAC, whichever is higher) plus any dispensing fee, and they must share detailed payment data with the state Prescription Drug Affordability Board. It also penalizes manufacturers who withdraw a drug to escape the price limit.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HF 5156 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HF 5156 freeOr ask your AI assistant about HF 5156 directly:
Add to Claude, ChatGPT or Cursor